Research & Development



  婦人們聚會,雲瑯不好過去,朝她們揮揮手就去了後山,何愁有已經三天沒有出現在雲氏內宅了,這很奇怪,雲瑯想去看看何愁有,看看他到底出了什麼事情。   老令官面對如此場景,難道都不動心嗎?”青青草   看到了利潤的主家,覺得奴隸利用的效率還能再開發一下,用在他們身上的費用還能再減免一點。青青草视频   至于他說還有兩年蹦噠的余地,是他自己寬慰自己的話,劉徹要辦事,等不到天明的。   阿嬌不理睬曹襄,而是看著雲瑯道︰“沒想到你連番邦人釀造葡萄釀的法門都知道,還真是小看你了。”青青草在线视频   “比如呢?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo